Liver transplantation for hereditary tyrosinemia type I: analysis of the UNOS database

Ronen Arnon1, Rachel Annunziato, Tamir Miloh

  • 1Department of Pediatrics, Mount Sinai School of Medicine, New York, NY, USA. Ronen.arnon@mountsinai.org

Insights

Liver transplantation (LT) is a vital treatment for children with tyrosinemia type 1 (HT-1) experiencing liver failure. The study shows LT is effective, with survival rates of 90.4%, and its use has declined due to early diagnosis and treatment.

Area of Science:

  • Hepatology
  • Pediatric Gastroenterology
  • Transplant Surgery

Background:

  • Hereditary tyrosinemia type 1 (HT-1) can lead to progressive liver disease and hepatocellular carcinoma (HCC).
  • Liver transplantation (LT) is a critical intervention for HT-1 patients with fulminant liver failure, HCC, or medically refractory decompensated chronic liver disease.

Purpose of the Study:

  • To evaluate the indications for and outcomes of LT in children diagnosed with HT-1.
  • To analyze trends in LT for HT-1 over a 20-year period.

Main Methods:

  • Retrospective analysis of the UNOS database for pediatric patients with HT-1 who underwent LT between October 1987 and May 2008.
  • Statistical comparison of transplant characteristics and survival rates.

Main Results:

  • 125 (1.1%) of 11,467 pediatric patients in the UNOS database had HT-1 requiring LT.
  • The mean age at LT increased significantly from the first decade (1.82 years) to the second decade (3.70 years) of the study (p=0.01).
  • Overall one- and five-year patient survival rates post-LT were 90.4%.

Conclusions:

  • LT remains a valuable option for children with HT-1 facing severe liver complications.
  • The decreasing rate and increasing age at LT suggest improved early diagnosis and treatment with nitisinone (NTBC) have reduced the need for transplantation.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...